BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29751067)

  • 1. Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.
    Shi X; Kitano A; Jiang Y; Luu V; Hoegenauer KA; Nakada D
    Exp Hematol; 2018 Aug; 64():33-44.e5. PubMed ID: 29751067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia.
    Tothova Z; Krill-Burger JM; Popova KD; Landers CC; Sievers QL; Yudovich D; Belizaire R; Aster JC; Morgan EA; Tsherniak A; Ebert BL
    Cell Stem Cell; 2017 Oct; 21(4):547-555.e8. PubMed ID: 28985529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice.
    Li BE; Li GY; Cai W; Zhu Q; Seruggia D; Fujiwara Y; Vakoc CR; Orkin SH
    Blood Adv; 2023 Sep; 7(18):5281-5293. PubMed ID: 37428871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
    Ueda K; Ikeda K
    Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis.
    Zhang Q; Zhao L; Yang Y; Li S; Liu Y; Chen C
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 35132955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
    Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
    Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells.
    Abdelfattah NS; Mullally A
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.
    Kotini AG; Chang CJ; Chow A; Yuan H; Ho TC; Wang T; Vora S; Solovyov A; Husser C; Olszewska M; Teruya-Feldstein J; Perumal D; Klimek VM; Spyridonidis A; Rampal RK; Silverman L; Reddy EP; Papaemmanuil E; Parekh S; Greenbaum BD; Leslie CS; Kharas MG; Papapetrou EP
    Cell Stem Cell; 2017 Mar; 20(3):315-328.e7. PubMed ID: 28215825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
    Brunetti L; Gundry MC; Kitano A; Nakada D; Goodell MA
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Majeti R
    Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Models of Myeloid Malignancies.
    Basheer F; Vassiliou G
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 32071146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
    Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E Pluribus Unum ("Out of Many, One"): CRISPR Modeling of Myeloid Expansion.
    Shin J; Corn JE
    Cell Stem Cell; 2017 Oct; 21(4):415-416. PubMed ID: 28985519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
    Chopra M; Bohlander SK
    Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
    Lin S; Wei J; Wunderlich M; Chou FS; Mulloy JC
    Oncotarget; 2016 Aug; 7(35):55939-55950. PubMed ID: 27509060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone.
    van Lom K; Hagemeijer A; Vandekerckhove F; de Greef GE; Sacchi N; Löwenberg B
    Leukemia; 1997 Feb; 11(2):202-5. PubMed ID: 9009081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34
    Cromer MK; Vaidyanathan S; Ryan DE; Curry B; Lucas AB; Camarena J; Kaushik M; Hay SR; Martin RM; Steinfeld I; Bak RO; Dever DP; Hendel A; Bruhn L; Porteus MH
    Mol Ther; 2018 Oct; 26(10):2431-2442. PubMed ID: 30005866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.